NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+32.7%
5Y CAGR+106.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+32.7%/yr
Annual compound
5Y CAGR
+106.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
37.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $248.13M | +11.8% |
| 2024 | $221.85M | +12.6% |
| 2023 | $197.06M | +85.5% |
| 2022 | $106.25M | +203.8% |
| 2021 | $34.98M | +427.4% |
| 2020 | $6.63M | - |